DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
95 hedge funds and large institutions have $838M invested in Dicerna Pharmaceuticals, Inc. in 2018 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 37 increasing their positions, 20 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
95
Holders Change
+10
Holders Change %
+11.76%
% of All Funds
2.18%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.14%
New
20
Increased
37
Reduced
20
Closed
10
Calls
$10K
Puts
–
Net Calls
+$10K
Net Calls Change
+$1.54M
Top Buyers
| 1 |
BM
Bridger Management
New York
|
$84.4M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
$17.6M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
$58M |
| 4 |
Goldman Sachs
New York
|
$20.7M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$30.3M |
